These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17979658)

  • 41. Gene silencing mediated by small interfering RNAs in mammalian cells.
    Scherr M; Morgan MA; Eder M
    Curr Med Chem; 2003 Feb; 10(3):245-56. PubMed ID: 12570711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral applications of RNAi.
    Morris KV; Rossi JJ
    Curr Opin Mol Ther; 2006 Apr; 8(2):115-21. PubMed ID: 16610763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes.
    Watanabe T; Totoki Y; Toyoda A; Kaneda M; Kuramochi-Miyagawa S; Obata Y; Chiba H; Kohara Y; Kono T; Nakano T; Surani MA; Sakaki Y; Sasaki H
    Nature; 2008 May; 453(7194):539-43. PubMed ID: 18404146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC.
    Castanotto D; Sakurai K; Lingeman R; Li H; Shively L; Aagaard L; Soifer H; Gatignol A; Riggs A; Rossi JJ
    Nucleic Acids Res; 2007; 35(15):5154-64. PubMed ID: 17660190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Most recent findings on microRNA-dependent regulation of drug metabolism].
    Nakano M; Nakajima M
    Nihon Yakurigaku Zasshi; 2019; 154(1):28-34. PubMed ID: 31308347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation.
    Hutvagner G
    FEBS Lett; 2005 Oct; 579(26):5850-7. PubMed ID: 16199039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Illuminating the silence: understanding the structure and function of small RNAs.
    Rana TM
    Nat Rev Mol Cell Biol; 2007 Jan; 8(1):23-36. PubMed ID: 17183358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug disposition in pathophysiological conditions.
    Gandhi A; Moorthy B; Ghose R
    Curr Drug Metab; 2012 Nov; 13(9):1327-44. PubMed ID: 22746301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNA interference: mechanisms, technical challenges, and therapeutic opportunities.
    Sioud M
    Methods Mol Biol; 2015; 1218():1-15. PubMed ID: 25319642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vector-based delivery of siRNAs: in vitro and in vivo challenges.
    Walchli S; Sioud M
    Front Biosci; 2008 May; 13():3488-93. PubMed ID: 18508450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer.
    Abbasi M; Lavasanifar A; Uludag H
    Med Res Rev; 2013 Jan; 33(1):33-53. PubMed ID: 21523793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of liver diseases on drug-metabolizing enzymes: implications for drug fate alterations and nano-therapeutic openings.
    Lu L; Shi J; Li Q; Peng X; Dong L; Li Y; Dai P; Wang Y; Guo E; Zhou F; Liu Z
    Curr Med Chem; 2014; 21(22):2522-41. PubMed ID: 24358976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local and systemic delivery of siRNAs for oligonucleotide therapy.
    Takeshita F; Hokaiwado N; Honma K; Banas A; Ochiya T
    Methods Mol Biol; 2009; 487():83-92. PubMed ID: 19301643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemical modification of siRNA.
    Deleavey GF; Watts JK; Damha MJ
    Curr Protoc Nucleic Acid Chem; 2009 Dec; Chapter 16():Unit 16.3. PubMed ID: 20013783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional Gene Regulation in Drug Metabolism and Disposition.
    Tu MJ; Yu AM
    Curr Drug Metab; 2023; 24(3):175-189. PubMed ID: 37170982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A plasmid-based system for expressing small interfering RNA libraries in mammalian cells.
    Kaykas A; Moon RT
    BMC Cell Biol; 2004 Apr; 5():16. PubMed ID: 15119963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The silent treatment: siRNAs as small molecule drugs.
    Dykxhoorn DM; Palliser D; Lieberman J
    Gene Ther; 2006 Mar; 13(6):541-52. PubMed ID: 16397510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
    DeVincenzo JP
    Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.